Outcomes of Patients With COVID-19 in the Intensive Care Unit
MexCOVID-19
1 other identifier
observational
150
1 country
2
Brief Summary
The objective of this study is to evaluate the clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit. A Multicenter Observational Study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2020
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2020
CompletedFirst Submitted
Initial submission to the registry
April 2, 2020
CompletedFirst Posted
Study publicly available on registry
April 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 4, 2020
CompletedNovember 10, 2020
October 1, 2020
29 days
April 2, 2020
November 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital mortality
Mortality 30 days following hospital admission
30 days
Secondary Outcomes (1)
Length of stay in the intensive care unit
Through study completion, an average of 30 days
Eligibility Criteria
Critically ill patients aged over 18 years with a positive for SARS-CoV-2 result required admission to an intensive care unit or critical care in other areas of the hospital (critical care surge capacity).
You may qualify if:
- Confirmed case: Critically ill patient who meets the operational definition of a suspected case and who has a confirmed diagnosis by the National Network of Public Health Laboratories recognized by the Institute of Epidemiological Diagnosis and Reference (Indre) (Mexico).
You may not qualify if:
- If a negative for SARS-CoV-2 result is obtained from a critically ill patient with a high index of suspicion for COVID-19 virus infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, 14000, Mexico
All centres from Mexico willing to contribute are Welcome.
México, Mexico
Related Publications (1)
Namendys-Silva SA, Alvarado-Avila PE, Dominguez-Cherit G, Rivero-Sigarroa E, Sanchez-Hurtado LA, Gutierrez-Villasenor A, Romero-Gonzalez JP, Rodriguez-Bautista H, Garcia-Briones A, Garnica-Camacho CE, Cruz-Ruiz NG, Gonzalez-Herrera MO, Garcia-Guillen FJ, Guerrero-Gutierrez MA, Salmeron-Gonzalez JD, Romero-Gutierrez L, Canto-Castro JL, Cervantes VH; Mexico COVID-19 Critical Care Collaborative Group. Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study. Heart Lung. 2021 Jan-Feb;50(1):28-32. doi: 10.1016/j.hrtlng.2020.10.013. Epub 2020 Oct 21.
PMID: 33138974RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Silvio A. Ñamendys-Silva, MD, MSc
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- STUDY DIRECTOR
Guillermo Dominguez-Cherit, MD
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- STUDY CHAIR
Eduardo Rivero-Sigarroa, MD
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 2, 2020
First Posted
April 7, 2020
Study Start
April 1, 2020
Primary Completion
April 30, 2020
Study Completion
June 4, 2020
Last Updated
November 10, 2020
Record last verified: 2020-10